Inventor · disambiguated record
Martin Pass
Also filed as: PASS MARTIN
8 granted patents·14 pending applications·87 citations·filing 1992–2007
86Inventor score
Top patents by PatentIndex Score
22 records- 0185US7893063B22,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancerASTRAZENECA AB·Filed 2005·Granted Feb 22, 2011·12 cites·10 claims
- 0285US6677316B2Adenosine derivatives and methods of administrationSMITHKLINE BEECHAM CORP·Filed 2002·Granted Jan 13, 2004·26 cites·13 claims
- 0378US6326386B1Benzamide derivatives as thrombin inhibitorsGLAXO GROUP LTD·Filed 2000·Granted Dec 4, 2001·9 cites·14 claims
- 0471US6670381B2Benzamide derivatives as thrombin inhibitorsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Dec 30, 2003·5 cites·19 claims
- 0570US6492348B1Adenosine derivativesSMITHKLINE BEECHAM CORP·Filed 1999·Granted Dec 10, 2002·27 cites·30 claims
- 0663US7084148B2Substituted pyrimidines as selective cyclooxygenase-2 inhibitorsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Aug 1, 2006·1 cites·23 claims
- 0757US2007088044A1Quinazoline derivatives as antitumor agentsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 0852US2007082921A1Quinazoline derivatives as antitumor agentsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 0950US2005282845A1Substituted pyrimidines as selective cyclooxygenase-2 inhibitorsCARTER MALCOLM C·Filed 2005·Application pending·0 cites
- 1048US2005043336A1Quinazoline derivatives as antitumor agentsFiled 2002·Application pending·0 cites
- 1147US2005054662A1Quinazoline derivatives as antitumor agentsFiled 2002·Application pending·0 cites
- 1244US6441008B1Benzamide derivatives as thrombin inhibitorsSMITHKLINE BEECHAM CORP·Filed 1999·Granted Aug 27, 2002·5 cites·10 claims
- 1344US2009270390A1Pyrimidine derivativesASTRAZENECA·Filed 2007·Application pending·0 cites
- 1444US2010022534A12-benzimidazolyl-6-morpholino-4- (azetidine, pyrrolidine, piperidine or azepine) pyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disordersASTRAZENECA·Filed 2007·Application pending·0 cites
- 1542US2007149560A1Novel fused triazolones and the uses thereofASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 1641US2009233926A12-benzimidazolyl-6-morpholino-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disordersASTRAZENECA·Filed 2007·Application pending·0 cites
- 1740US2009275567A12-heterocycloamino-4-imidazolylpyrimidines as agents for the inhibition of cell proliferationJONES CLIFFORD·Filed 2007·Application pending·0 cites
- 1839US2008051401A12,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of CancerPASS MARTIN·Filed 2005·Application pending·0 cites
- 1939US2010267755A1Pyrimidine derivativesGLAXO GROUP LTD·Filed 2002·Application pending·0 cites
- 2038US2009325954A12-benzimidazolyl-6-morpholino-4-phenylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disordersBUTTERWORTH SAM·Filed 2007·Application pending·0 cites
- 2137US2008058332A12,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of CancerBAILEY JOHN P·Filed 2005·Application pending·0 cites
- 2235US5317023ABenzofuran derivativesGLAXO GROUP LTD·Filed 1992·Granted May 31, 1994·2 cites·25 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →